QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

USDA expands biobased product push—with private industry funding the ads

H.R. 4832 — Biomanufacturing and Jobs Act of 2025 · Filed by Mark Alford (R-MO) · 7 cosponsors · Introduced Aug 1, 2025 · Referred to committee

65%
Transparency
Typical bill: 82%
18/100
Hidden-provision risk
Typical bill: 15/100
Agricultural Market Development & Rural…

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill expands the USDA's BioPreferred Program, which promotes biobased products (made from agricultural commodities like corn and soybeans) by requiring federal agencies to purchase more of them and establishing clearer labeling standards. It creates a task force to coordinate USDA research and marketing of biobased products, allows the USDA to accept private funding for promotional campaigns, and updates federal procurement systems to track biobased purchases. The bill benefits farmers and rural economies by creating new markets for agricultural feedstock, and benefits biomanufacturers by increasing federal demand and market visibility.

Why we flagged it

The bill's core mechanism is expanding federal procurement and labeling of biobased agricultural products to create new markets for farmers and rural manufacturers. While it benefits specific industries (biomanufacturers, agricultural commodity producers), the stated purpose—rural economic development and petroleum reduction—is genuine and publicly articulated.

What the text implies

  • The bill allows the USDA to accept private (non-federal) funding for marketing biobased products without appropriation limits, potentially creating a public-private marketing apparatus where private biomanufacturers fund government promotion of their own products—blurring the line between public education and industry advertising.
  • Federal procurement requirements may increase costs to agencies if biobased products carry price premiums; the bill allows agencies to exceed price thresholds but does not cap or fund the difference, potentially shifting budget pressure to other agency priorities.

The full analysis lists 4 implications of this text.

Who stands to gain

biomanufacturers and biobased product companies; agricultural commodity producers (corn, soybean farmers); rural development contractors and suppliers

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record